These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9044323)

  • 1. Anticipation of end-stage renal disease in autosomal dominant polycystic kidney disease.
    Gonzalo A; Gallego A; San Millan JL; Ortuño J
    Nephrol Dial Transplant; 1996; 11 Suppl 6():21-3. PubMed ID: 9044323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)?
    Geberth S; Ritz E; Zeier M; Stier E
    Nephrol Dial Transplant; 1995; 10(9):1603-6. PubMed ID: 8559477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticipation of end stage renal disease in patients with autosomal dominant polycystic kidney disease in successive generations.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Cristodoulidou C; Spaia S; Mavromatidis K
    Ren Fail; 2001 Sep; 23(5):715-20. PubMed ID: 11725918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in age at ESRD in autosomal dominant polycystic kidney disease.
    Reed BY; McFann K; Bekheirnia MR; Nobakhthaghighi N; Masoumi A; Johnson AM; Shamshirsaz AA; Kelleher CL; Schrier RW
    Am J Kidney Dis; 2008 Feb; 51(2):173-83. PubMed ID: 18215695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there evidence for anticipation in autosomal-dominant polycystic kidney disease?
    Fick GM; Johnson AM; Gabow PA
    Kidney Int; 1994 Apr; 45(4):1153-62. PubMed ID: 8007586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension in polycystic kidney disease type 1 and 2 and its effect on the age of onset of end-stage renal disease.
    Torra R; Badenas C; Pérez L; Estivill X; Darnell A
    Contrib Nephrol; 1997; 122():28-30. PubMed ID: 9399033
    [No Abstract]   [Full Text] [Related]  

  • 7. Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
.
    Nowak KL; Chonchol M; You Z; Gupta M; Gitomer B
    Clin Nephrol; 2018 Mar; 89(3):196-204. PubMed ID: 29035198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal failure appears earlier in men than in women with polycystic kidney disease.
    Stewart JH
    Am J Kidney Dis; 1994 Aug; 24(2):181-3. PubMed ID: 8048422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfamilial and intrafamilial variability of clinical expression in ADPKD.
    Torra R; Darnell A; Estivill X; Botey A; Revert L
    Contrib Nephrol; 1995; 115():97-101. PubMed ID: 8585926
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
    Lee KB; Kim UK
    Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dominant polycystic renal disease. Study of 105 cases].
    Kheder A; Ben Hamida F; el Younsi F; Abderrahim E; Safar M; Ben Ayed H; Ben Maiz H
    Rev Med Interne; 1992; 13(5):345-8. PubMed ID: 1344829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.
    Sági B; Késői I; Késői B; Vas T; Csiky B; Kovács T; Nagy J
    Physiol Int; 2018 Jun; 105(2):145-156. PubMed ID: 29975128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.
    Gabow PA; Johnson AM; Kaehny WD; Kimberling WJ; Lezotte DC; Duley IT; Jones RH
    Kidney Int; 1992 May; 41(5):1311-9. PubMed ID: 1614046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplant Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Versus Other Recipients: A 10-Year Report From South of Iran.
    Roozbeh J; Malekmakan L; Harifi MM; Tadayon T
    Exp Clin Transplant; 2018 Dec; 16(6):676-681. PubMed ID: 27759554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KHA-CARI Autosomal Dominant Polycystic Kidney Disease Guideline: Management of End-Stage Kidney Disease.
    Lee VW; Tunnicliffe DJ; Rangan GK
    Semin Nephrol; 2015 Nov; 35(6):595-602.e12. PubMed ID: 26718164
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease.
    Fourtounas C; Panteris V; Valis D
    Am J Kidney Dis; 2002 Mar; 39(3):660. PubMed ID: 11877589
    [No Abstract]   [Full Text] [Related]  

  • 19. More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.
    Geberth S; Stier E; Zeier M; Mayer G; Rambausek M; Ritz E
    J Am Soc Nephrol; 1995 Dec; 6(6):1643-8. PubMed ID: 8749692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nature and nurture on phenotypic variability of autosomal dominant polycystic kidney disease.
    Pei Y
    Kidney Int; 2005 Apr; 67(4):1630-1. PubMed ID: 15780121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.